Cite
P525: LONG-TERM OUTCOMES OF STEM CELL TRANSPLANT IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH VENETOCLAX + HMA THERAPIES
MLA
Keith Pratz, et al. “P525: Long-Term Outcomes of Stem Cell Transplant in Older Patients with Acute Myeloid Leukemia Treated with Venetoclax + Hma Therapies.” HemaSphere, vol. 7, Aug. 2023. EBSCOhost, https://doi.org/10.1097/01.HS9.0000969008.68978.fe.
APA
Keith Pratz, Courtney Dinardo, Martha L Arellano, Michael Thirman, Vinod Pullarkat, Pamela S. Becker, B. Douglas Smith, Meng Zhang, Michael E Werner, Jalaja Potluri, & Daniel A. Pollyea. (2023). P525: Long-Term Outcomes of Stem Cell Transplant in Older Patients with Acute Myeloid Leukemia Treated with Venetoclax + Hma Therapies. HemaSphere, 7. https://doi.org/10.1097/01.HS9.0000969008.68978.fe
Chicago
Keith Pratz, Courtney Dinardo, Martha L Arellano, Michael Thirman, Vinod Pullarkat, Pamela S. Becker, B. Douglas Smith, et al. 2023. “P525: Long-Term Outcomes of Stem Cell Transplant in Older Patients with Acute Myeloid Leukemia Treated with Venetoclax + Hma Therapies.” HemaSphere 7 (August). doi:10.1097/01.HS9.0000969008.68978.fe.